SCHEDULE: Viemed Healthcare Insider Sets Up Stock Sale Plan

Michael Moore and Moore Faster LLC have filed an amendment to their Schedule 13D, reporting changes in beneficial ownership and establishing a Rule 10b5-1 trading plan for the sale of up to 246,000 Viemed Healthcare shares.

Summary

• Michael Moore and Moore Faster LLC have filed Amendment No. 3 to their Schedule 13D, updating their beneficial ownership of Viemed Healthcare, Inc. (VMD) common shares.
• The amendment reports that Michael Moore beneficially owns 2,294,018 shares (5.9% of the class), including shares held by Moore Faster LLC (MF LLC) and exercisable options.
• MF LLC beneficially owns 1,585,812 shares (4.2% of the class).
• A key update is the adoption of a Rule 10b5-1 trading plan by MF LLC with Morgan Stanley Smith Barney LLC, effective September 24, 2026.
• Under this plan, MF LLC may sell up to 246,000 shares between a Selling Start Date (no earlier than December 24, 2026) and November 30, 2027.
• The plan was adopted when neither Moore nor MF LLC were aware of material non-public information.
• The filing details various stock option and restricted stock unit grants and vesting events for Michael Moore over several years.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as moderately positive, primarily due to the establishment of a Rule 10b5-1 trading plan, which provides a structured approach to potential future sales and signals a degree of forward planning by management.

Positives

• Establishment of a Rule 10b5-1 trading plan by Moore Faster LLC, providing a structured and compliant method for potential future share sales.
• The trading plan was adopted at a time when the reporting persons were not aware of material non-public information, adhering to regulatory requirements.
• Michael Moore's beneficial ownership is clearly detailed, including directly held shares, shares held by MF LLC, and exercisable options.

Negatives

• The potential sale of up to 246,000 shares by Moore Faster LLC could exert downward pressure on the stock price if executed.
• The filing details a history of stock option exercises and sales by Michael Moore, indicating ongoing portfolio management.

Risks

• The potential for significant share sales under the 10b5-1 plan could impact the stock's market price.
• Future vesting of stock options and restricted stock units could lead to additional shares becoming available for sale.

Future Outlook

Moore Faster LLC has adopted a Rule 10b5-1 trading plan to sell up to 246,000 shares of Viemed Healthcare, Inc. between late 2026 and November 2027, subject to predetermined trading conditions. This plan is intended to provide an affirmative defense against allegations of insider trading.

Management Comments

• Each of the Reporting Persons holds the Common Shares as reported herein for investment purposes and does not have any specific plans or proposals regarding the Issuer in such Reporting Person's capacity as a holder of Common Shares.
• Except as set forth below, each of the Reporting Persons does not have any current plans or proposals which relate to, or may result in, any of the matters listed in Items 4(a)-(j) of Schedule 13D.

Industry Context

StockSavvy.ai notes that the establishment of Rule 10b5-1 plans is a common practice for corporate insiders to manage their stock holdings in a compliant manner, especially when facing potential liquidity needs or portfolio diversification goals. This filing indicates a proactive approach by Michael Moore and Moore Faster LLC to manage their investment in Viemed Healthcare.

Related Party Transactions

• Michael Moore transferred 1,722,614 Common Shares to MF LLC for estate planning purposes on August 14, 2023.
• Michael Moore owns 50% of the ownership units in MF LLC and serves as its general manager.

Stakeholder Impact

• Shareholders may observe potential downward pressure on the stock price if a significant number of shares are sold under the 10b5-1 plan.
• The establishment of the 10b5-1 plan provides transparency regarding potential future selling activity by a major holder.

Next Steps

• Moore Faster LLC may begin selling shares under the Rule 10b5-1 trading plan starting no earlier than December 24, 2026.
• Sales under the plan will continue until November 30, 2027, subject to trading conditions.
• The company will continue to file required SEC disclosures regarding beneficial ownership and other material events.

Key Dates

Recommendation

The filing primarily concerns the establishment of a Rule 10b5-1 trading plan by a significant beneficial owner, Michael Moore, and Moore Faster LLC. While this indicates a potential for future selling activity, it is a structured and compliant approach. The filing does not contain new operational or financial performance data that would warrant a buy or sell recommendation. Therefore, a 'hold' stance is appropriate, pending further developments or financial disclosures from Viemed Healthcare.

Keywords

Viemed Healthcare, Schedule 13D, Rule 10b5-1, Stock Sale Plan, Beneficial Ownership, Insider Trading, Morgan Stanley, Moore Faster LLC